Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
Int Braz J Urol
; 46(suppl.1): 125-132, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-603713
ABSTRACT
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Biomedical Research
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Int Braz J Urol
Journal subject:
Urology
Year:
2020
Document Type:
Article
Affiliation country:
S1677-5538.IBJU.2020.S118
Similar
MEDLINE
...
LILACS
LIS